What is the treatment for Plasmodium malariae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Plasmodium Malariae

Treat uncomplicated P. malariae malaria with chloroquine: 600 mg base initially, followed by 300 mg base at 24 hours, and 150 mg base at 48 hours (total 1,500 mg base over 3 days). 1, 2, 3

Why Chloroquine Remains First-Line

  • P. malariae has not developed chloroquine resistance, unlike P. falciparum which shows widespread resistance globally 4, 5
  • Chloroquine is safe during pregnancy and can be used in all trimesters 1, 2
  • The FDA-approved dosing for adults is 1 g salt (600 mg base) initially, then 500 mg salt (300 mg base) at 6-8 hours, followed by 500 mg salt daily for 2 consecutive days 3

Pediatric Dosing

  • Children require 25 mg/kg total dose over 3 days: 10 mg/kg base on day 0,10 mg/kg base at 24 hours, and 5 mg/kg base at 48 hours 1, 2
  • The pediatric dose should never exceed the adult dose regardless of weight 3

Critical Distinction: No Primaquine Needed

  • P. malariae does NOT require primaquine for radical cure because it lacks the hypnozoite liver stage that causes relapses 1
  • This is a key difference from P. vivax and P. ovale, which do require 8-aminoquinoline therapy 1, 2
  • Adding primaquine unnecessarily exposes patients to risk of hemolysis without any benefit 1

When to Consider Alternative Therapy

  • If chloroquine-resistant P. malariae is suspected (extremely rare), artemisinin-based combination therapy (ACT) can be used 6, 7
  • Artemether-lumefantrine: 4 tablets at 0 and 8 hours on day 1, then 4 tablets twice daily on days 2-3, taken with fatty food 6, 7
  • Dihydroartemisinin-piperaquine: 3-4 tablets daily for 3 days (based on weight), taken while fasting 6, 7

Monitoring and Follow-Up

  • Administer the first chloroquine dose when blood smear is obtained 2
  • If symptoms persist beyond 3 days, obtain repeat blood smear to assess parasitemia reduction 1, 2
  • Expect clinical improvement within 48 hours and confirm parasite clearance with follow-up blood smears 2

Supportive Care

  • Use acetaminophen/paracetamol for fever control 7, 2
  • Increase fluid intake to prevent dehydration from febrile illness 7, 2
  • For children with high fevers, frequent tepid water sponging is recommended 1, 7

Common Pitfalls to Avoid

  • Do not add primaquine routinely - P. malariae has no hypnozoite stage and primaquine adds unnecessary hemolysis risk 1
  • Do not confuse P. malariae with P. vivax or P. ovale, which do require primaquine for radical cure 1, 2
  • Minor chloroquine side effects include gastrointestinal disturbance, headache, dizziness, and blurred vision, but serious adverse effects are rare at prophylactic doses 2
  • Chloroquine may exacerbate psoriasis and interfere with antibody response to intradermal rabies vaccine 2

Severe Malaria (Rare with P. Malariae)

  • If severe malaria develops (impaired consciousness, shock, pulmonary edema, acidosis, severe anemia), intravenous artesunate is first-line therapy: 2.4 mg/kg IV at 0,12, and 24 hours 7, 2
  • Transition to oral chloroquine when parasitemia is <1% and patient can tolerate oral medication 7

References

Guideline

Treatment of Plasmodium Malariae

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chloroquine Treatment Regimens and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Malaria Surveillance - United States, 2017.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002), 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Mixed Malaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.